GoWithFund
Sign in
🥗Weight Loss• Sustainable Weight Management, Macro Tracking & Non-Crash Dieting

Weight Loss Medication Comparison: Questions to Ask

How GLP-1s and other classes differ, what evidence shows, and the questions to bring to your doctor.

GoWithFund Editorial Team
GoWithFund Editorial Team
••7 min read
Doctor and patient reviewing weight loss medication options during a consultation
Quick Answer

A weight loss medication comparison is not about picking a winner; it is about understanding which class fits your health profile, budget and goals before you talk with your doctor. Prescription weight loss drugs differ in how they work, how much weight people typically lose in trials, side effects, and access. This guide compares the main options neutrally so you can walk into your appointment with sharper questions. It is educational, not personal medical advice.

🌱
Key takeaways
  • GLP-1 and dual GIP/GLP-1 drugs show the largest average trial results, but they are not right for everyone.
  • Older options like orlistat and phentermine are cheaper or shorter-term, with more modest or narrower use cases.
  • Side effects, contraindications, cost and insurance coverage often matter as much as effectiveness.
  • Medication works best alongside calorie balance, protein, activity and consistent tracking.
  • Bring a written list of questions, your history and your goals to your prescriber.

A weight loss medication comparison is not about picking a winner; it is about understanding which class fits your health profile, budget and goals before you talk with your doctor. Prescription weight loss drugs differ in how they work, how much weight people typically lose in trials, side effects, and access. This guide compares the main options neutrally so you can walk into your appointment with sharper questions. It is educational, not personal medical advice.

Key Takeaways

  • GLP-1 and dual GIP/GLP-1 drugs show the largest average trial results, but they are not right for everyone.
  • Older options like orlistat and phentermine are cheaper or shorter-term, with more modest or narrower use cases.
  • Side effects, contraindications, cost and insurance coverage often matter as much as effectiveness.
  • Medication works best alongside calorie balance, protein, activity and consistent tracking.
  • Bring a written list of questions, your history and your goals to your prescriber.

What does a weight loss medication comparison actually involve?

A useful weight loss medication comparison weighs five things together:mechanism. No single drug is best for every adult, and guidelines generally reserve medication for people with obesity or overweight plus related conditions, alongside lifestyle treatment.

Definition: Prescription weight loss drugs are medicines approved to support chronic weight management in adults, usually alongside nutrition, activity and behavioral changes. They are tools, not replacements for habits.

Think of the comparison as a decision framework rather than a ranking.Your clinician will weigh BMIce. The same drug can be a strong option for one person and a poor fit for another.

The main medication classes and how they work

Most prescription weight loss drugs fall into a few families. Knowing the mechanism helps you predict side effects and ask better questions. Below is a plain-English map of the landscape.

GLP-1 receptor agonists

GLP-1 drugs mimic glucagon-like peptide-1, a gut hormone that increases satiety, slows stomach emptying and helps regulate appetite and glucose. Semaglutide 2.4 mg (Wegovy) and liraglutide 3.0 mg (Saxenda) are the best-known examples. They are injected, usually weekly for semaglutide and daily for liraglutide.

Dual GIP/GLP-1 receptor agonists

Tirzepatide (Zepbound) activates both GIP and GLP-1 receptors. In trials it produced larger average weight loss than earlier GLP-1 agents, though individual response varies and tolerability still matters.

Older and adjunct options

Orlistat (Xenical, Alli) blocks some fat absorption in the gut. Phentermine is a stimulant-like appetite suppressant generally used short term. Naltrexone-bupropion (Contrave) acts on appetite and reward pathways. These are not interchangeable, and each has distinct cautions.

ClassExamplesHow it worksTypical use
GLP-1 agonistSemaglutide, liraglutideSatiety, slower gastric emptyingChronic weight management
Dual GIP/GLP-1TirzepatideTwo incretin pathwaysChronic weight management
Lipase inhibitorOrlistatReduces fat absorptionAdjunct to diet
StimulantPhentermineAppetite suppressionShort-term use
Opioid/dopamine modulatorNaltrexone-bupropionAppetite and reward signalingChronic use with monitoring

What does the trial data show on average results?

Trial averages are useful benchmarks, not personal guarantees. In the STEP 1 trial published in the New England Journal of Medicine, semaglutide 2.4 mg produced roughly 15% average body-weight reduction versus about 2% with placebo over 68 weeks. In SURMOUNT-1, tirzepatide 15 mg produced roughly 21% average loss versus about 3% with placebo over 72 weeks.

Liraglutide 3.0 mg in the SCALE trial averaged around 8% weight loss versus about 3% with placebo. Orlistat typically adds a few percentage points beyond lifestyle alone, and phentermine is generally studied over shorter horizons. Naltrexone-bupropion trials showed average losses around 5% versus placebo, with meaningful nonresponse rates.

Two honest caveats matter. First, trial participants received structured lifestyle support, so real-world results are often smaller. Second, weight regain after stopping medication is common, which is why these are usually framed as long-term treatments rather than short courses.

A weight loss medication comparison should ask not only how much weight people lost on average, but what happens after the drug is stopped, and what support surrounds it.
Weekly weight loss injection pen beside a balanced high-protein meal and tracking notebook

Common side effects and who should avoid them

Side effects are the main reason people stop weight loss drugs, so they deserve equal billing with effectiveness. GLP-1 and dual agonists most often cause nausea. Rare butserious risks include pancreatitis; labels warn against use in people with personal or family history of medullary thyroid carcinoma or MEN 2.

Who should be cautious?

  • People with a history of pancreatitis or severe gastrointestinal disease.
  • Those who are pregnant, trying to conceive or breastfeeding.
  • People with uncontrolled hypertension or significant cardiovascular disease for stimulant options.
  • Anyone with seizure disorders or eating disorders for naltrexone-bupropion.
  • People with chronic diarrhea or fat-soluble vitamin concerns for orlistat.

This is general education, not a clearance list. Only your clinician can match contraindications to your history, and they may order baseline labs, review current medications and schedule follow-ups.

Cost, access and insurance realities

Cost is often the deciding factor in a weight loss medication comparison. Branded GLP-1 and dual agonists can be expensive without coverage, and insurers frequently require documented BMI thresholds, comorbidities, prior lifestyle attempts or prior authorization. Coverage policies change, so verify benefits directly with your insurer and pharmacy before assuming affordability.

Practical access steps include asking about prior authorization, manufacturer savings programs, formulary alternatives and whether a compounded product is appropriate and legal in your situation. Be cautious with compounded or gray-market versions; quality and dosing oversight vary. If cost blocks one option, your doctor may suggest a different class, a structured lifestyle-first plan, or referral to a weight-management specialist.

Why medication works best with habits and tracking

Medication reduces appetite; it does not build protein intake, sleep, movement or consistency. The strongest results in trials came with lifestyle counseling, and real-world success usually depends on the same boring fundamentals:calorie awareness.

Tracking turns vague effort into feedback. Weekly weigh-ins, waist measurements, habit streaks and trend charts help you see whether the plan is working before the scale stalls. The GoWithFund Weight Loss app supports exactly this loop with weigh-ins, habit tracking and trend charts, making it easier to bring objective data to follow-up visits. A soft but sensible pairing: let the prescription handle appetite, and let your tracking handle accountability.

Smartphone showing a weight trend chart next to a scale and walking shoes

Questions to ask your doctor before starting

Bring this checklist to your appointment. It converts a vague weight loss medication comparison into a personalized decision.

  1. Which class fits my BMI, conditions and medications, and why?
  2. What average results should I expect, and how will we define success at 12 and 24 weeks?
  3. What side effects are most likely for me, and when should I call?
  4. Which contraindications or family history rules this out?
  5. What will this cost monthly, and what does my insurance require?
  6. How long would I stay on it, and what happens if I stop?
  7. What labs or follow-ups do we need before and during treatment?
  8. What nutrition, protein and activity plan should pair with it?
  9. How will we track progress beyond the scale?
  10. What is our plan if this drug does not work or is not tolerated?

Frequently Asked Questions

Which weight loss drug is most effective?

On average in trials, tirzepatide and semaglutide show the largest weight reductions, around 15-21% in pivotal studies. Individual response varies, and tolerability, cost and contraindications often decide the best fit.

Are GLP-1 drugs safe for long-term use?

GLP-1 drugs are studied for chronic use, but they require medical monitoring and are not safe for everyone. Your doctor should review pancreatitis history, thyroid cancer history, pregnancy plans and current medications first.

Can I stop weight loss medication once I reach my goal?

Stopping often leads to regaining some weight, so most guidelines treat these as long-term therapies. Discuss a maintenance plan, continued tracking and lifestyle support before discontinuing.

Do I need medication if diet and exercise have not worked?

Not necessarily, but medication is a legitimate option when lifestyle efforts alone have not produced enough results, especially with obesity-related conditions. A clinician can help decide whether it fits your situation.

How fast do prescription weight loss drugs work?

Appetite changes can appear within weeks, while meaningful weight change usually shows over 8-12 weeks and continues for months. Dose escalation is gradual to limit side effects.

Will insurance cover weight loss medication?

Sometimes, but coverage varies widely and often requires prior authorization, BMI criteria or documented comorbidities. Call your insurer and ask your prescriber about formulary options and savings programs.

Conclusion: compare, then personalize

A smart weight loss medication comparison is less about finding a miracle drug and more about matching evidence, safety, cost and habits to your life. Use the classes, trial benchmarks and checklist above to have a focused conversation with your doctor, then track the result honestly. If you want a simple way to log weigh-ins, habits and trends between visits, the GoWithFund Weight Loss app can keep the data organized at gowithfund.com.

Keshav Gautam
Verified E-E-A-T Author

Keshav Gautam

Director, GoWithFund Inc.

Published on behalf of GoWithFund Inc., a registered U.S. 501(c)(3) tax-exempt public charity in Idaho (EIN: 33-1243835 | Idaho SOS #5902503). Articles are reviewed for statutory compliance under IRS Internal Revenue Code Section 170.

GoWithFund Weight Loss0% Platform Fee Ecosystem

Track Weight & Build Sustainable Habits

Log weigh-ins with moving-average smoothing, track protein and hydration habits, and reach your goals without crash diets.

100% Donor Funds DeliveredInstant Stripe Direct DepositNo Monthly Retainers
Recommended Reading
Explore all Weight Loss guides
Balanced meal prep with a habit tracker notebook and scale, illustrating a sustainable weight loss strategy
🥗 Weight & Habits
Nov 22, 2026•8 min read

Sustainable Weight Loss Strategy: A Guide to Long-Term Success

Learn how a sustainable weight loss strategy works: habits, calorie balance, plateaus and long-term success you can actually keep.

GoWithFund Editorial Team

GoWithFund Editorial Team

Staff Contributor

Read
Person checking their weight trend on a smartphone after reaching their goal weight
🥗 Weight & Habits
Nov 22, 2026•8 min read

Maintenance Calories After Weight Loss: Exit Guide

Made simple: step up intake, watch trend lines, and adjust before regain starts.

GoWithFund Editorial Team

GoWithFund Editorial Team

Staff Contributor

Read
Weight Loss Web App Strategic Implementation Guide - GoWithFund Weight Loss Guide Cover Visual
🥗 Weight & Habits
Nov 22, 2026•5 min read

Weight Loss Web App: Strategic Implementation Guide

Sustainable metabolic habit tracking: smoothed moving-average weigh-ins, macro adherence, and lifestyle protocols for weight loss web app in-depth guide.

GoWithFund Support

GoWithFund Support

Director, GoWithFund Inc.

Read
Weight Loss Web App Strategic Implementation Guide - GoWithFund Weight Loss Guide Cover Visual
🥗 Weight & Habits
Nov 22, 2026•5 min read

Weight Loss Web App: Strategic Implementation Guide

Sustainable metabolic habit tracking: smoothed moving-average weigh-ins, macro adherence, and lifestyle protocols for weight loss web app in-depth guide.

GoWithFund Support

GoWithFund Support

Director, GoWithFund Inc.

Read
Adult checking weight on a digital scale at home during a post-diet maintenance routine
🥗 Weight & Habits
Nov 22, 2026•8 min read

How to Stop Weight Regain After Dieting: A Real Plan

With maintenance calories, refeed structure and early-warning tracking you can sustain.

GoWithFund Editorial Team

GoWithFund Editorial Team

Staff Contributor

Read